RecruitingNCT06921902

Glycemic Metrics and Patterns in People With and Without Prediabetes

Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)

Sponsor

Abbott Diabetes Care

Enrollment

2,000 participants

Start Date

Feb 28, 2025

Study Type

OBSERVATIONAL

Conditions

Pre-diabetes

Summary

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called FreeStyle Libre 3 for people with pre-diabetes. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFreeStyle Libre 3

Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)

Locations(1)

Diabetes and Obesity Care

Bend, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06921902

Related Trials

7-Ketolithocholic Acid in Prediabetes

NCT076501238 locations

Sisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health in Farmworker Women

NCT071110261 location